Posts by Taylor Thompson, MD
-
COVID-19 ARDS Has Distinct Phenotypes Different from Those in "Classic" ARDS
Massachusetts General Hospital physicians have identified two phenotypes of acute respiratory distress syndrome (ARDS) associated with COVID-19 that are distinct in biochemical profiles and short-term mortality despite minimal differences in respiratory dynamics.
Biography
Dr. Thompson is a California native who joined the Department of Medicine and the Pulmonary and Critical Care Unit at MGH in 1985. He directed the Pulmonary and Critical Care Fellowship training program until 1990 and the Medical Intensive Care Unit until 2011. He now the Director of Critical Care Translational Research in the Pulmonary and Critical Care Unit. His current patient care activities are focused solely on caring for critically ill patients and their families. He has been actively involved in teaching at Harvard Medical School where he is a Professor of Medicine. He has been an active clinical investigator for over 25 years. His primary research and academic interests involve managing clinical trials for patients with the Acute Respiratory Distress Syndrome (ARDS) or severe sepsis, investigating the molecular epidemiology of ARDS and sepsis, and developing and testing computerized bedside decision support tools.